Treatment with tetrahydrocannabinologists (THC) prevents inflammatory bowel disease (IBD) – Crohn’s disease and ulcerative colitis. Which, in turn, reduces the risk the development of colorectal cancer.
In a recent study by scientists at South Carolina State University, it was found that treatment with tetrahydrocannabinol (THC), a substance found in cannabis, prevents the development of colon cancer in mice. It was found that THC suppresses inflammation in the colon, preventing the development of tumors that appear due to carcinogens.
“The fact that we were able to show that THC treatment prevents inflammation in the colon and at the same time suppresses the development of cancer supports the notion that inflammation and cancer are closely related. Patients with a higher risk of colon cancer, THC or other anti-inflammatory agents may be helpful, “said Prakash Nagarkatti, MD, one of the authors of the project.
Cancer Prevention – Formerly Glavred reported: